Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe Read more about Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe
Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering Read more about Iovance Biotherapeutics, Inc. Announces Closing of $252 Million Common Stock Public Offering
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock Read more about Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $220 Million of Common Stock
Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock Read more about Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock
Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program Read more about Iovance Biotherapeutics Reports Results from FDA End of Phase 2 meeting and Provides Updates About the Company’s Clinical Program
Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare Conference Read more about Iovance Biotherapeutics to Present at the 2018 Cantor Global Healthcare Conference
Iovance Biotherapeutics to Present at Two Investor Conferences in September Read more about Iovance Biotherapeutics to Present at Two Investor Conferences in September
Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center Read more about Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update Read more about Iovance Biotherapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018 Read more about Iovance Biotherapeutics to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018